PSA, PSA derivatives, proPSA and prostate health index in the diagnosis of prostate cancer
Abstract Currently, prostate- specific antigen (PSA) is the most common oncological marker used for prostate cancer screening. However, high levels of PSA in benign prostatic hyperplasia and prostatitis decrease the specificity of PSA as a cancer marker. To increase the specificity of PSA, PSA deri...
שמור ב:
| מחבר ראשי: | |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Turkish Association of Urology
2019-07-01
|
| סדרה: | Urology Research and Practice |
| נושאים: | |
| גישה מקוונת: | http://urologyresearchandpractice.org/index.php/pub/article/view/2776 |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|